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Summary
Desmoplastic small round cell tumor (DSRCT) is defined genetically by the chimeric fusion of the Ewing’s sarcoma and
Wilms’ tumor genes, generating a novel transcription factor, EWS-WT1. By using cells with inducible EWS-WT1 to screen
high-density microarrays, we identified BAIAP3 as a transcriptional target of the chimera. The BAIAP3 promoter is specifi-
cally bound in vivo by the (KTS) isoform of EWS-WT1, consistent with its activation in reporter assays. BAIAP3 encodes a
protein implicated in regulated exocytosis, which is colocalized with a secreted growth factor within cytoplasmic organelles.
Ectopic expression of BAIAP3 in tumor cells dramatically enhances growth in low serum and colony formation in soft agar.
BAIAP3 therefore encodes a transcriptional target of an oncogenic fusion protein that implicates the regulated exocytotic
pathway in cancer cell proliferation.
Introduction DSRCT carry a translocation of the EWS NTD to three of the
four zinc finger domains of the Wilms’ tumor suppressor WT1.
DSRCT is an aggressive neoplasm arising from the serosalDistinct chromosomal translocations involving the EWS gene
surfaces of the abdominal peritoneum, primarily affecting youngat chromosome 22q12 underlie a number of primitive tumor
males (Gerald and Rosai, 1989). Tumor cells express specifictypes, including Ewing’s sarcoma, malignant melanoma of soft
epithelial, muscle, and neural markers, suggesting a pluripotentparts, myxoid liposarcoma, myxoid chondrosarcoma, and des-
cell of origin (Gerald et al., 1991; Gerald and Rosai, 1993). Themoplastic small round cell tumor (DSRCT) (reviewed in de Alava
tumor itself has a remarkable histological appearance, with smalland Gerald, 2000). These translocations result in the generation
nests of tumor cells surrounded by a dense reactive stromaof novel chimeric proteins, all of which contain the N-terminal
containing fibroblasts and hyperplastic blood vessels. As such,domain (NTD) of EWS, encoding a potent transactivation domain
DSRCT provides an exceptional model for paracrine interactions
(Bailly et al., 1994; May et al., 1993; Ohno et al., 1993), which
between the tumor and stromal cell compartments that con-
is fused to the DNA binding domains of different transcription tribute to human cancer. All cases of DSRCT carry the
factors. The remarkable selectivity for different cell types dis- t(11;22)(p13;q12) translocation, fusing the NTD of EWS with the
played by these oncogenic transcription factors is presumably C-terminal zinc fingers 2 through 4 of WT1 (Figure 1A) (Gerald
derived to a great extent from the activation of different sets of et al., 1995; Ladanyi and Gerald, 1994). WT1 encodes a tran-
transcriptional targets, whose identity is dictated by the DNA scription factor that is essential for normal kidney development,
binding specificity of the EWS translocation partner. The sus- which is inactivated in a subset of Wilms’ tumors, leukemias,
ceptibility of specific cell types to the transforming effect of and mesotheliomas (reviewed in Lee and Haber, 2001). Four
these genes may also contribute to their lineage restriction. C-terminal C2-H2 zinc fingers mediate DNA binding to the con-
Ewing’s sarcoma is defined by a translocation of the EWS NTD sensus 5-GCGTGGGAGTA-3 sequence (Nakagama et al.,
to the DNA binding domain of one of the related ETS proteins, 1995); a prevalent alternative splicing event inserts three amino
acids, lysine, threonine, and serine (KTS), between zinc fingersFLI1 and ERG (Arvand and Denny, 2001). Similarly, all cases of
S I G N I F I C A N C E
Chromosomal translocations which fuse the Ewing’s sarcoma gene EWS to different DNA binding domains result in the creation of
chimeric transcription factors that define specific types of embryonal tumors. Transcriptional targets activated by these oncogenic
fusion proteins drive malignant transformation, and they may identify novel pathways involved in tumorigenesis. By generating cells
with inducible expression of the EWS-WT1 chimera and interrogating expression arrays, we identified a target gene, BAIAP3, that
appears to function in regulated exocytosis, a pathway that has not previously been linked to cancer. BAIAP3 is of particular interest,
since it is also expressed in breast and prostate cancers and its ectopic expression enhances malignant properties of cancer cells.
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Figure 1. Induction of BAIAP3 by EWS-WT1 and expression in DSRCT
A: Schematic representation of the EWS-WT1 fusion protein. The NTD transactivation and RNA binding domains of EWS are indicated, along with the
transactivation and zinc finger DNA binding domains of WT1. KTS represents the three amino acids, lysine, threonine, and serine, that are alternatively
spliced within the WT1 zinc finger domain. The first zinc finger of WT1 is consistently excluded from the chimera, but the KTS splice is preserved.
B: Northern blot analysis of U2OS cells with tetracycline-repressible expression of WT (/KTS) and EWS-WT1 (/KTS) following growth in the presence ()
or absence () of tetracycline (tet) for 12 hr. Blots were probed for BAIAP3, WT1 (recognizing both WT1 and EWS-WT1), and GAPDH (loading control).
C: Comparison of the domain structure of human (h) BAIAP3 (NP_003924) and rat (r) Munc13-1(NP_620199) proteins, including the C1, C2, and Munc13
homology domains.
D: Northern blot analysis of representative primary specimens from Wilms’ tumor, Ewing’s sarcoma, and DSRCT. Variability in the intensity of EWS-WT1 reflects
differences in the relative composition of tumor and stromal cells as well as RNA integrity.
E: RNA in situ hybridization of BAIAP3 in two primary DSRCT samples (40). Adjacent sections are stained with hemotoxylin and eosin (H&E) showing the
basophilic tumor cell nests (arrowheads) surrounded by dense reactive stroma. BAIAP3 expression is restricted to tumor cells. No staining was observed
with a control sense probe (not shown).
3 and 4 and disrupts binding to this element. WT1(KTS) trans- responsive promoters. Indeed, Platelet-derived growth factor-
A (PDGF-A) and Insulin-like growth factor-1 receptor (IGF-1-R),activates a number of genes implicated in cellular differentiation,
whereas the function of WT1(KTS) in transcription is less clear both of which have promoters that are modulated by
WT1(KTS) in reporter assays, were also found to be regulated(reviewed in Lee and Haber, 2001). The EWS-WT1 chimera
invariably loses the first zinc finger of WT1, suggesting an im- by EWS-WT1(KTS) (Finkeltov et al., 2002; Karnieli et al., 1996;
Lee et al., 1997). However, despite the in vitro binding of EWS-portant difference in DNA binding specificity. However,
the (/KTS) alternative splice is preserved, with EWS- WT1(KTS) to promoters that are also recognized by native
WT1(KTS), few appear to be regulated by EWS-WT1 in vivoWT1(KTS), but not the (KTS) variant, mediating potent tran-
scriptional activation (Kim et al., 1998b; Rauscher et al., 1994). (Kim et al., 1998b; Lee et al., 1997; Rauscher et al., 1994). We
therefore used cells with inducible expression of EWS-Initial attempts at identifying physiological transcriptional
targets of EWS-WT1(KTS) focused on genes with WT1- WT1(KTS) to search for endogenous transcripts whose ex-
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pression is altered following induction of the chimeric fusion. Direct regulation of the BAIAP3 promoter by EWS-WT1
The strong and rapid (12 hr) induction of endogenous BAIAP3Hybridization to high-density oligonucleotide microarrays was
mRNA following inducible expression of EWS-WT1(KTS) sug-used as an unbiased screen for novel EWS-WT1(KTS) target
gests the presence of a responsive element (E-WRE) within thegenes, followed by validation using Northern blotting and pro-
BAIAP3 promoter. Two isoforms of BAIAP3 have been identi-moter characterization. Here, we report a novel gene, BAIAP3,
fied, BAIAP3 (AL834321) and BAIAP3 (AB017111). Thesewhich is transcriptionally regulated by EWS-WT1(KTS), but
isoforms differ in the alternative usage of exon 1 versus exonnot by native WT1(KTS). BAIAP3 appears to function in the
1, associated with different transcriptional start sites and pre-process of regulated exocytosis, raising the possibility that
sumptive regulatory sequences (Figure 2A). RT-PCR andEWS-WT1-dependent transformation may rely, in part, on this
5-RACE analyses of either U2OS cells with inducible EWS-pathway.
WT1(KTS) or normal tissues with constitutive expression of
BAIAP3 (such as fetal brain) confirmed expression of only theResults
BAIAP3 isoform (data not shown). The proximal promoter for
the BAIAP3 transcript contains multiple elements similar toInduction of BAIAP3 by EWS-WT1(KTS)
the EWS-WT1(KTS) consensus binding site, E-WRE, found inIn order to undertake an unbiased screen for EWS-WT1(KTS)
the IL-2/15R promoter: 5-(G/C)(C/G)(G/C)TGGGGG-3 (Wongtarget genes, we generated U2OS human osteosarcoma cells
et al., 2002). Element B1 (nucleotides 443 to 458; sensewith tightly regulated, tetracycline-repressible expression of this
5-GCTGTGGGCGTGGGGC-3) contains two overlapping E-WREisoform (Lee et al., 1997), and interrogated high-density oligonu-
sites, and element B2 (nucleotides 264 to 272; antisensecleotide microarrays for transcripts whose expression was al-
5-GCGTGGGGT-3) has a single site (Figure 2B). Transcrip-tered following induction of the chimera. Total cellular RNA
tional activation of the BAIAP3 promoter by EWS-WT1(KTS)was isolated 12 hr following drug withdrawal and compared in
was demonstrated following transient transfection of luciferase-duplicate with RNA from cells grown under identical conditions
reporter constructs into U2OS cells. Four-fold induction wasin the presence of tetracycline. Known genes found to be in-
reproducibly observed using reporter plasmid pGL3-B, con-duced by EWS-WT1(KTS) have been previously reported and
taining both E-WRE sites and lacking a 3 GC-rich negativeinclude interleukin-2/15 receptor  (IL-2/15R), platelet-derived
regulatory element (Figure 2C). Consistent with the EWS-growth factor-A (PDGF-A), adrenomedulin, amphiregulin, and
WT1(KTS)-specific induction of the endogenous BAIAP3 tran-
fibroblast growth factor receptor 4 (Wong et al., 2002). Addition-
script, the reporter constructs were not activated by either wild-
ally, several ESTs were also identified as putative EWS-
type WT1(KTS) or by the (KTS) isoform of the chimera.
WT1(KTS) targets. One of these, EST (R60906), displayed the
We used electrophoretic mobility shift assays (EMSA) to
highest fold induction (79.4 and 160.8 in duplicate experiments) determine whether EWS-WT1(KTS) binds to the B1 and B2
as compared with all other identified targets, and was therefore elements within the BAIAP3 promoter in vitro. Promoter re-
characterized further. By a combination of cDNA library screen- gions containing either element bound efficiently to the bacteri-
ing and database mining, this EST was found to be derived ally synthesized EWS-WT1(KTS) zinc finger domain, whereas
from the 3 untranslated region of BAIAP3 (first described as no binding was observed with the EWS-WT1(KTS) control
BAP3 [Shiratsuchi et al., 1998]), a C2 domain containing protein (Figure 2D). To confirm this interaction in vivo, we used chroma-
hypothesized to function in regulated exocytosis (Figure 1C). tin immunoprecipitation (ChIP) to enrich for DNA fragments
Northern blot analysis confirmed that the 2.5 kb and 4.8 kb bound by EWS-WT1(KTS). Proteins bound to DNA in U2OS
BAIAP3 transcripts are below detection in U2OS cells and are cells in which expression of the chimera had been induced by
strongly induced within 12 hr following expression of EWS- the removal of tetracycline were crosslinked using formalde-
WT1(KTS) (Figure 1B). In contrast, no induction of BAIAP3 is hyde, and EWS-WT1 protein-DNA complexes were immunopre-
observed following expression of either native WT1(KTS) or cipitated using antibodies against either the WT1 zinc finger
EWS-WT1(KTS). Thus, induction of BAIAP3 is specific for domain or the C-terminal HA-epitope tag. With induction of
the transcriptionally active EWS-WT1(KTS) isoform of the EWS-WT1(KTS), specific BAIAP3 promoter sequences were
chimera. selectively enriched in both the anti-WT1 and anti-HA immuno-
The use of a heterologous cell type with tetracycline-regu- precipitates relative to control (-actin) sequences (Figure 2E).
lated expression of EWS-WT1 makes it possible to effectively No enrichment was observed in the absence of antibody or in
screen microarrays for downstream targets, but these must be mock immunoprecipitated samples (rabbit preimmune serum).
confirmed in the relevant tumor cells. We therefore screened As an additional negative control, these experiments were re-
multiple primary DSRCT samples for expression of BAIAP3, first peated with cells grown in the presence of tetracycline. In the
by Northern blot analysis, followed by RNA in situ hybridization. absence of induction of EWS-WT1(KTS), only minimal enrich-
Expression of the expected BAIAP3 transcripts is readily evident ment of the BAIAP3 promoter was observed (data not shown).
in two DSRCT specimens but not in sporadic Wilms’ tumor Based on these results, EWS-WT1(KTS) binds to the BAIAP3
expressing wild-type WT1 or in Ewing’s sarcoma containing the promoter both in vitro and in vivo.
EWS-FLI1 rearrangement (Figure 1D). A characteristic feature
of these tumors, small nests of tumor cells surrounded by a Expression of BAIAP3 in epithelial cell types
dense reactive or “desmoplastic” stroma, is demonstrated upon and intracellular localization
histological analysis of DSRCT tumor sections. RNA in situ anal- BAIAP3 was originally identified as a brain specific protein, po-
ysis in four DSRCT specimens indicated strong BAIAP3 expres- tentially involved in the regulation of neurotransmitter release
sion specifically within the nests of tumor cells and not within (Shiratsuchi et al., 1998). Our observation that it is also ex-
pressed at high levels in primary DSRCT specimens raised thethe surrounding reactive stroma (Figure 1E and data not shown).
CANCER CELL : DECEMBER 2002 499
R E P O R T
Figure 2. Direct transcriptional activation of
BAIAP3 by EWS-WT1(KTS)
A: Schematic representation of the 5 end of the
BAIAP3 gene. BAIAP3 represents the transcript
induced by EWS-WT1(KTS), utilizing exon 1.
BAIAP3 denotes the originally published cDNA
sequence for BAIAP3, which utilizes exon 1, but
was not detectable in cells studied here. The
transcriptional start site of BAIAP3 (arrow) is de-
rived from the EST database (BI546056) and 5
RACE experiments.
B: Schematic representation of the BAIAP3 pro-
moter upstream of exon 1 denoting the posi-
tions of two potential EWS-WT1 binding sites, B1
(443 to 458) and B2 (264 to 272), along
with a GC-rich sequence. Fragments I and II rep-
resent regions used for EMSA.
C: Activation of the BAIAP3 promoter by EWS-
WT1(KTS). Luciferase activity, relative to vector-
transfected cells, was measured in U2OS cells
following cotransfection of CMV-driven expres-
sion constructs and the indicated reporter (see
Experimental Procedures). Standard deviations
were derived from three experiments.
D: EMSA analysis of promoter fragments I and II,
following incubation with GST-conjugated zinc
finger domains of EWS-WT1 (/ KTS) or GST
alone. Migration positions of free probe (P) and
DNA-protein complexes (arrowheads) are
shown. Multiple shifted bands may represent the
ability of 1 molecule of EWS-WT1(KTS) to bind
to each fragment.
E: Chromatin immunoprecipitation demonstra-
ting in vivo association of EWS-WT1(KTS) with
the BAIAP3 promoter. Multiplex PCR of BAIAP3
promoter together with -actin promoter (nega-
tive control), using templates derived from cross-
linked DNA-protein complexes immunoprecipi-
tated with either two different antibodies against
EWS-WT1 (C19 against the WT1-derived DNA
binding domain or HA against the epitope tag),
nonspecific antibodies (rabbit preimmune serum, Mock), or an antibody to acetylated histone H4 ( histone; positive control). Progressive dilutions of total
chromatin were also amplified to demonstrate the linearity of multiplex PCR amplification (Input).
possibility that it may be involved in additional functions in other al., 2000; Koch et al., 2000; Shiratsuchi et al., 1998) (Figure 1C).
Given the absence of reliable functional assays, we first testedcell types. Therefore, we examined the expression pattern of
BAIAP3 by both RNA in situ hybridization and semiquantitative whether BAIAP3 is physically colocalized with bona fide mem-
bers of this cellular pathway. The PC12 cell line is derived fromRT-PCR in mouse and human tissues. As expected, specific
structures of the developing brain, including the cortical plate, adrenal chromaffin cells of rat pheochromocytoma and contains
multiple secretory vesicles that fuse with the cell membrane inventricular zone, ganglionic eminence, pyriform (olfactory) cor-
tex, and thalamus, express high levels of BAIAP3 (Figure 3A). response to a shift in intracellular Ca2 levels. Transient transfec-
tion of a plasmid encoding human growth hormone (hGH) intoHowever, expression of BAIAP3 is also present in nonneuronal
tissues, including placenta, lung, pancreas, spleen, and testes these cells serves as a marker for secretory vesicles (Wick et
al., 1993). Indeed, cotransfection of hGH and HA-tagged(Figure 3A and data not shown). Within the placenta, expression
of BAIAP3 mRNA is restricted to the syncytiotrophoblasts, cells BAIAP3 into PC12 cells shows colocalization of the two proteins
within small cytoplasmic structures consistent with secretorythat secrete growth factors such as chorionic gonadotropin and
placental lactogen (Morrish et al., 1998). BAIAP3 mRNA is also vesicles (Figure 3B). This colocalization is supported by cell
fractionation experiments. Differential centrifugation showspresent in human breast and prostate tumor samples within
both the normal and malignant epithelial cells. These expression BAIAP3 to be present within the microsomal fraction (both in
high-density “HDM” and low-density “LDM” microsomal frac-studies suggest that BAIAP3 may function in a number of differ-
ent secretory cell types. tions) with only a small amount present in the cytosolic fraction
(Figure 3C). This microsomal localization is also seen for theA potential role for BAIAP3 in regulated exocytosis was
postulated based on the sequence and spatial organization of its secretory vesicle markers synaptotagmin and synaptophysin,
whereas the cytosolic protein RhoGDi is almost exclusively lo-two Ca2/phospholipid binding (C2) domains and two Munc13-
homology domains (MHD), all of which are highly similar to those calized within the cytosolic fraction. Further separation of HDM
and LDM fractions on a discontinuous sucrose gradient demon-of Munc13 proteins, essential regulators of neurotransmitter
release, a specialized form of regulated exocytosis (Brose et strates overlap of BAIAP3 with the two vesicle proteins. Taken
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Figure 3. Tissue-specific expression and localiza-
tion of BAIAP3
A: RNA in situ hybridization analysis of BAIAP3,
demonstrating expression in E18.5 fetal mouse
brain, within the ventricular zone (VZ), cortical
plate (CP), thalamus (TH), ganglionic eminence
(GE), and pyriform (olfactory) cortex (CPf). No
staining was observed with the sense control;
bar 	 0.3 mm. BAIAP3 is also expressed at high
levels in the mouse placenta, specifically within
syncytiotrophoblasts (arrowheads); bar 	 0.4
mm. Inset shows a higher magnification of the
syncytiotrophoblast layer; bar 	 0.1 mm. Expres-
sion is present in normal human breast epithe-
lium, where multiple lobules are lined with BAIAP3
positive epithelial cells (arrowheads), and both
normal and cancerous human prostate (note
BAIAP3 positive epithelial cells lining glands);
bar 	 0.1 mm.
B: Confocal imaging of PC12 cells expressing HA-
tagged BAIAP3 and hGH. Cells were stained with
antibody to the HA-epitope (green fluores-
cence) and antibody to hGH (red fluorescence),
with regions of overlap (yellow) evident on the
merged image.
C: Biochemical fractionation of BAIAP3 within
subcellular fractions from PC12 cells. Cytosolic,
high-density microsomal (HDM) and low-density
microsomal (LDM) fractions were isolated using
differential centrifugation. HDM and LDM frac-
tions were pooled and further fractionated on
a discontinuous sucrose gradient. Western blot
analysis of collected fractions is shown, using an-
tibodies to the HA-epitope (BAIAP3), synapto-
tagmin, synaptophysin, and RhoGDi.
together, these studies support an association between BAIAP3 its effect on in vitro correlates of malignant transformation. For
these experiments, we used the human melanoma cell line MCand secretory vesicles, implicating BAIAP3 in regulated exo-
cytosis pathways in neuronal cells, specialized cells of the pla- (Bartolazzi et al., 1994), and we generated multiple independent
clones following transfection with either BAIAP3 or vector con-centa, and both normal and malignant epithelial cells.
trol, to ensure against clonal selection bias (Figure 4A and data
not shown). Cells expressing BAIAP3 were not altered in theirBAIAP3 promotes neoplastic transformation
Ectopic expression of EWS-WT1(KTS) has been reported to baseline growth properties. However, they consistently demon-
strated a dramatically enhanced proliferation at limiting serumbe weakly transforming in NIH3T3 cells (Kim et al., 1998a).
Further studies have been limited by uncertainty as to the cell concentrations (0.5% serum), as compared with vector-trans-
fected cells (Figure 4B). A similar effect on serum dependenceof origin of DSRCT and the inability to generate DSRCT cell
lines in vitro. We therefore used ectopic expression of BAIAP3 was observed following transfection of BAIAP3 into NIH3T3
cells (data not shown). BAIAP3-expressing MC cells were alsoin human tumor cells of borderline invasiveness to determine
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Figure 4. Effect of BAIAP3 on cellular proliferation
and transformation
A: RT-PCR amplification of BAIAP3 mRNA from
five stably transfected melanoma cell lines, MCB
46, 50, 51, 52, and 56. Two control cell lines trans-
fected with vector (MCV4 and MCV7) are nega-
tive for BAIAP3 expression.
B: Growth curve of multiple independent
BAIAP3- and vector-transfected cell lines main-
tained in medium containing 0.5% fetal bovine
serum for a total of 10 days.
C and D: Colony formation in soft agar. C: Frac-
tion of cells from multiple BAIAP3- and vector-
transfected lines plated in soft agar and giving
rise to colonies with0.5 mm diameter. D: Repre-
sentative plates are shown for vector-trans-
fected cell lines (MCV) and BAIAP3-transfected
cells (MCB), either at no magnification (left) or
40 magnification to show individual colonies
(right).
tested for anchorage independent growth. Whereas vector- nation of inducible expression in a heterologous cell type with
high-density microarray analysis to undertake an unbiasedtransfected MC cells form small (0.15 mm) colonies following
screen for potential targets of EWS-WT1. We demonstrate thatplating on soft agar, BAIAP3-expressing cells give rise to large
BAIAP3 is a transcriptional target of the chimera, that its expres-colonies (0.5 mm diameter) with a plating efficiency of 30%–
sion pattern in primary tumor specimens is consistent with a50% (Figures 4C and 4D). Finally, inoculation of 3  106 vector-
physiologically relevant role in DSRCT, and that its ectopic ex-transfected MC cells into ten nude mice produced one tumor
pression enhances the neoplastic properties of human tumorat 9 weeks, consistent with the reported weak tumorigenicity
cells. While we do not fully understand the mechanism wherebyof this cell line (Bartolazzi et al., 1994). In contrast, by this time
BAIAP3 modulates these in vitro correlates of malignant trans-point, tumors were present in four out of ten mice that had
formation, its apparent function within the regulated exocytosisbeen inoculated with either of two BAIAP3-transfected cell lines.
pathway raises the possibility that growth factor secretion byTaken together, these observations support a role for BAIAP3
tumor cells may play a role in DSRCT.in reducing the need for exogenous growth factors present in
Initial in vitro studies of the EWS-WT1 chimera had sug-serum, enhancing anchorage independent proliferation in vitro,
gested that the derivation of its three zinc finger domains fromand contributing toward tumorigenicity in vivo. The EWS-
WT1 might result in binding to a similar set of target genesWT1(KTS) chimeric construct itself displays modest trans-
recognized by the four zinc fingers of native WT1(KTS). How-forming properties in heterologous cell types, a feature that is
ever, analysis of endogenous transcripts regulated by theseshared with other EWS-related translocation products (Arvand
transcription factors has suggested that these targets are, foret al., 1998; Lessnick et al., 2002). Only few MC clones tolerated
the most part, distinct. For instance, we have previously demon-
expression of EWS-WT1(KTS) at low levels, and these formed
strated that the transcripts encoding PDGF-A and the IL2/15
colonies with a plating efficiency of 30% in soft agar but did
receptor are both induced by EWS-WT1(KTS), but expression
not enhance tumor formation in nude mice (data not shown). The of these transcripts is not altered by native WT1(KTS) (Lee et
ability of MC cells to tolerate expression of the EWS-WT1(KTS) al., 1997; Wong et al., 2002). Similarly, amphiregulin mRNA
target BAIAP3 therefore made it possible to detect its contribu- is strongly induced by WT1(KTS), but only weakly by EWS-
tion to neoplastic transformation. WT1(KTS) (Lee et al., 1999; Wong et al., 2002). Consistent
with these observations, we find that BAIAP3 is induced by
Discussion EWS-WT1(KTS), but not by native WT1(KTS). This distinc-
tion may result in part from altered DNA binding specificity
Identification of transcriptional targets for EWS-WT1, the unique associated with the presence or absence of the first WT1 zinc
chimeric transcription factor underlying DSRCT, is essential for finger domain, although promoter context and protein interac-
insight into its mechanism of cellular transformation as well as its tions involving the EWS transactivation domain may also con-
remarkable cell type specificity. As for other EWS translocation- tribute to promoter specificity. The identification of BAIAP3 as
dependent cancers, the absence of established in vitro models a physiological transcriptional target of EWS-WT1(KTS) is fur-
and the uncertain cell of origin for the tumor itself have compli- ther supported by the demonstration of in vivo binding by the
cated efforts to identify the critical downstream pathways lead- chimera to its promoter using chromatin immunoprecipitation.
BAIAP3 was originally identified from a yeast two-hybriding to malignant transformation. Here, we have used the combi-
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assay searching for proteins interacting with the cytoplasmic targets for BAIAP3-dependent secretion in this tumor. In addi-
tion, growth factors that do have a leader sequence, includingdomain of brain angiogenesis inhibitor-1 (BAI1), although the
functional significance of this interaction is uncertain (Shiratsu- vascular endothelial growth factor (VEGF) and hGH, may be
secreted through similar pathways in specific cell types (Valterchi et al., 1998). Based on its C2 and Munc13 homology domains,
BAIAP3 belongs to a subfamily of Munc13-like proteins, some et al., 1999; Wick et al., 1993). The establishment of DSRCT
cell lines and functional assays will be required to determineof which are known to be essential for neurotransmitter release
(Koch et al., 2000; Shiratsuchi et al., 1998). Indeed, biochemical which growth factors may be critical for tumor growth. Targeting
the regulated exocytotic pathway may provide therapeutic op-fractionation suggests that BAIAP3 is present in microsomal
fractions that also contain important components of this path- tions in this otherwise refractory cancer.
way, synaptotagmin and synaptophysin, and BAIAP3 is coloca-
Experimental procedureslized with a cotransfected secreted growth factor within cellular
organelles. Knockout experiments have demonstrated the im-
Hybridization to oligonucleotide microarrays
portance of Munc13-1 in neurotransmitter release in mouse, and promoter characterization
along with its orthologs unc-13 in C. elegans and dunc-13 in U2OS cells with tetracycline-regulated, inducible expression of HA-tagged
Drosophila (Brose et al., 2000). However, the only in vitro func- EWS-WT1(KTS) were generated as described (Lee et al., 1997) and main-
tained in tetracycline (1 
g/ml). Expression profile analysis was performedtional assay, modulation of regulated exocytosis in PC12 cells,
using standard procedures for HuGeneFL chips (Affymetrix) (Lockhart et al.,has been inconsistent in demonstrating an effect for ectopic
1996). Briefly, poly(A) RNA was obtained from cells grown in the presenceexpression of Munc13-1 (Ashery et al., 2000; Sugita et al., 1999).
or absence of tetracycline for 12 hr, and used to generate labeled cRNA
Similarly, we also have not detected reproducible alterations in probes that were hybridized to oligonucleotide microarrays. A total of 21
this assay following ectopic expression of BAIAP3 (R.E.P., K. predicted targets (known genes and ESTs) were identified based on a greater
Mukherjee, T. Sudhof, and D.A.H., unpublished data). As regu- than 2 fold change in duplicate experiments, and for all candidates, induction
by EWS-WT1(KTS) was analyzed by Northern blotting. RT-PCR, 5-RACE,lated exocytosis is a multistep process involving recruitment of
and database mining were used to determine the approximate transcriptionalsecretory vesicles to the plasma membrane, followed by dock-
start site of the transcriptional target, BAIAP3. Two isoforms have beening, priming, and, finally, fusion with the membrane and secre-
described, BAIAP3 (AL834321) and BAIAP3 (AB017111). Only productstion of the enclosed molecules, the role of BAIAP3 may only be
representing BAIAP3 were detected; therefore, this isoform was used for
rate-limiting for selected steps in this pathway within specific all subsequent analyses. For luciferase reporter assays, BAIAP3 promoter
cell types. Munc13-1 functions during neurotransmitter vesicle sequences were cloned into the promoterless luciferase reporter pGL3 (Pro-
mega), and 0.2 
g of the reporter was cotransfected into U2OS cells (24-priming, a step that is conserved in endocrine, exocrine, and
well plates), along with 0.15 
g CMV-driven expression constructs encodingparacrine secretion (Ashery et al., 2000; Brose et al., 2000).
EWS-WT1(KTS), EWS-WT1(KTS), WT1(KTS), or empty vector. Thymi-Another protein family member that is closely related to BAIAP3,
dine kinase renilla reporter (5 ng) was cotransfected as a control for transfec-Munc13-4, is expressed in pulmonary goblet and alveolar type
tion efficiency, and luciferase activity was assayed using the Dual-Luciferase
II cells and implicated in exocrine secretion of mucous and Reporter assay system (Promega). All experiments were performed in trip-
surfactant (Koch et al., 2000). The expression of BAIAP3 in licate.
secretory syncytiotrophoblast cells of the placenta and in epi-
Electrophoretic mobility shift assaysthelial cells of the breast and prostate suggest a broader role
and chromatin immunoprecipitationin growth factor secretion. This model would be consistent with
For EMSA, polynucleotide-labeled probes (50,000 cpm) were incubated forthe decreased serum dependence observed in melanoma cells
20 min at room temperature with 500 ng of GST-conjugated EWS-WT1 zincexpressing ectopic BAIAP3.
finger domains, in binding buffer as described (Lee et al., 1999). For chroma-
The specific induction of BAIAP3 by the EWS-WT1 chimera tin immunoprecipitations, expression of HA-tagged EWS-WT1(KTS) in
suggests that the regulated exocytotic pathway may directly U2OS cells was induced by removal of tetracycline for 24 hr, and DNA-
contribute to pathogenesis in DSRCT. In addition to potential protein crosslinking was performed as described (Meluh and Broach, 1999)
with slight modifications. Formaldehyde was added to a final concentrationautocrine growth pathways, the characteristic histological ap-
of 1% and cells were incubated at room temperature for 20 min. Cellularpearance of DSRCT, small nests of tumor cells surrounded by
lysis and DNA shearing were performed in SDS lysis buffer (1% SDS, 10a dense desmoplastic reaction, also suggests paracrine interac-
mM EDTA, 50 mM Tris [pH 7.6], 1 protease inhibitor cocktail [Boeringer
tions between tumor and surrounding stroma. A fraction (14/ Mannheim]) with sonication to achieve an average DNA length of 400–500
43) of DSRCT tumors contain abundant dense core or neurose- bp. Samples were diluted to a final concentration of 0.1%SDS and incubated
cretory-like granules detectable by electron microscopy (Ordo- overnight at 4C with either 5 
l rabbit polyclonal anti-WT1(C-19) (Santa
nez, 1998). In addition, lysosome-like vesicles, whose secretion Cruz), 2 
l rabbit polyclonal anti-HA (Sigma), 1 
l mouse monoclonal anti-
acetylated histone H4, 2 
l rabbit preimmune serum (mock IP), or withoutis regulated by a similar mechanism, have been linked to the
an antibody. Samples were incubated with protein G sepharose and boundrelease of some leaderless secretory proteins, such as interleu-
complexes were eluted with 1% SDS, 0.1 M NaHCO3. Samples were incu-kin 1 (IL-1) (Andrei et al., 1999; Andrews, 2000; Blott and
bated 4 hr at 65C to reverse crosslinking and proteins were digested with
Griffiths, 2002). Growth factors that lack a leader sequence, Proteinase K. Following purification of DNA fragments (Qiaquick PCR purifi-
such as fibroblast growth factors 1 and 2 (FGF-1 and FGF-2), cation kit, Qiagen), promoter sequences were amplified using multiplex PCR.
are also dependent upon regulated exocytotic pathways for The following primer sets were used: BAIAP3, nt 1346–1761, accession
AL031709;-actin, nt 824–1103, accession number E00829. Coamplificationtheir secretion (Friesel and Maciag, 1999). These growth factors
of -actin within a multiplex reaction served as an internal control for enrich-have been shown to mediate cellular transformation in vitro
ment of BAIAP3 promoter sequences.(Blam et al., 1988; Jouanneau et al., 1991; Opalenik et al., 1995;
Rogelj et al., 1988) and to be associated with enhanced tumor
BAIAP3 cellular localization studies
growth in vivo (Kandel et al., 1991; Samaniego et al., 1995). The entire open reading frame of BAIAP3 was cloned, along with a 3 HA-
DSRCT samples express significant levels of both FGF-1 and tag, into the CMV-driven plasmid pcDNA3. This construct lacks the first
N-terminal 35 amino acids of the  transcript, whose presence could not2 (R.E.P. and W.L.G., unpublished data), making them potential
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